Tepoxalin
From Wikipedia, the free encyclopedia
"Zubrin" redirects here. For the aerospace engineer, see Robert Zubrin.
 |
|
|
Tepoxalin
|
|
| Systematic (IUPAC) name | |
| 3-[5-(4-Chlorophenyl)-1-(4-methoxyphenyl)pyrazol-3-yl]-N-hydroxy-N-methylpropanamide | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C20H20ClN3O3 |
| Mol. mass | 385.844 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Veterinary use only |
| Routes | Oral |
Tepoxalin is a nonsteroidal anti-inflammatory drug approved for veterinary use in the United States and the European Union. It is primarily used to reduce inflammation and relief of pain caused by musculoskeletal disorders such as Hip dysplasia and Arthritis, particularly in dogs.
It is generally marketed under the brand name Zubrin.
[edit] References
 |
This article does not cite any references or sources. (April 2008) Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed. |
 |
This veterinary medicine related article is a stub. You can help by expanding it. |
